Financial support of Selling and Marketing teams along with the Administrative functions (Finance, Legal, Human Resources and Information Technology) and leader of the Collaboration Accounting processes related to all partnerships. Drove budgeting and forecasting processes for over $300M in annual operating expenses, including 700+ of associated headcount, within 1% of budget for five years in a row. Designed and developed Product P&L’s for senior management to best determine potential profitability and help leverage revenue expectations with spending requirements on a quarterly basis. Provided in-depth analysis and analytical support to senior management regarding the decision to reduce sales force by over 200 heads, thus saving the company $44M in operating expense over a two year period. Built, led, and motivated a high performance team to support both the collaborations and planning functions with consistently accurate, timely, and data driven results. Facilitated a kaizen project to streamline the quarterly accounting and true up process with our partner, Eli Lilly, which saved 40 hours per quarter in preparation, review, and approval time. Created and automated management reporting tools, including dashboards and variance analysis reports, for 40+ departments saving two days each month for additional in-depth analysis and review.

Associate Director, Finance 2005 – 2008Finance Business Partner responsible for the financial support of the Selling and Marketing functions upon launch of Symlin and Byetta diabetes drugs in 2005. Assisted in the development, roll out, and completion of the new Cognos Planning process, on time and in time, for the 2006 planning cycle. Selected to lead the implementation of the interface of sales, A/R, and cash activities between our outside vendors and internal systems at the launch of both Symlin and Byetta. Developed, implemented, and maintained the Alliance function within Marketing / Sales to include planning, forecasting, monthly reporting, and interface with collaboration partner.Senior Manager, Finance 2002 – 2005Responsibilities included corporate planning, Treasury, risk management, and the capital approval and review process. Centralized all capital requests into a new process reducing approval through-time from up to two weeks to less than 5 days per request. Responsible for Corporate Planning in Hyperion. Maintained headcount, operating expenses, and capital spending and associated variance analyses to senior management each quarter. Directed all Risk Management activities. Point of contact and coordinator of annual renewal data and timely submissions to brokers as well as claims tracking.Manager, Finance (Recruited from Pyxis by former manager at Alaris) 2000 – 2002Managed corporate planning, cash management and treasury functions. Responsible for the Corporate Annual Budget and Forecast process to include presentations to senior management and the Board of Directors. Created a weekly cash-flow statement to keep senior management aware of spending levels and funding requirements.

Responsible for budgeting/forecasting and variance analysis for Marketing, R&D and Operations. Coordinated the implementation of a consistent ROI process for new products.

Alaris was formed in 1997 by the merger of IMED and IVAC to become the successor medical device company with a comprehensive portfolio of infusion devices, infusion software, connectivity solutions, and intravenous (IV) sets and accessories to significantly increase efficiency and enhance patient care. At peak, revenues of over $550M were supported by approximately 3,000 employees.Responsible for budgeting/forecasting, cash management, and risk management activities. Coordinated the conversion and implementation of the SAP Expense Planning module, as the Planning Process Expert, within deadline. Developed and formally taught the new SAP training process to all levels of management and staff, both in San Diego and North Carolina, to ensure a smooth and timely implementation.Held positions of increasing responsibility at IMED Corporation and IVAC Corporation upon graduation from SDSU to 1997.